Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Medtronic
QuintilesIMS
Teva
McKesson
Chubb
Harvard Business School
Healthtrust
Boehringer Ingelheim

Generated: July 18, 2018

DrugPatentWatch Database Preview

Ferric citrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ferric citrate and what is the scope of ferric citrate patent protection?

Ferric citrate
is the generic ingredient in one branded drug marketed by Keryx Biopharms and is included in one NDA. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric citrate has one hundred and eighteen patent family members in twenty-six countries.

There are sixteen drug master file entries for ferric citrate. One supplier is listed for this compound.
Pharmacology for ferric citrate
Synonyms for ferric citrate
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron salt (1:?)
1,2,3-propanetricarboxylic acid, 2-hydroxy-, iron(2+) salt (2:3)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt, hydrate (1:1:1)
1,2,3-Propanetricarboxylicacid, 2-hydroxy-, iron(3+) salt, hydrate (1:1:3)
1,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1)
11084-12-1
1185-57-5
12386-83-3
12549-57-4
153531-98-7
17217-76-4
17217-76-4 (trihydrate)
2-hydroxy-1,2,3-propanetricarboxylic acid iron salt
2-hydroxypropane-1,2,3-tricarboxylate; iron(3+)
2-hydroxypropane-1,2,3-tricarboxylic acid; iron
23087-37-8
2338-05-8
2338-05-8 (unspecified iron salt)
28633-45-6
28633-45-6 (unspecified iron(+3) salt)
334024-15-6
334S8T6LKE
3522-50-7
3522-50-7 (Parent)
3B1-003934
47516-89-2
5-hydroxy-2,8,9-trioxa-1-ferrabicyclo[3.3.2]decane-3,7,10-trione
57979-58-5 (dihydrate)
6043-74-9
62709-48-2
63G354M39Z
7705-15-9
A832727
AC1L1UYI
AC1NLT0S
ACM28633456
ACM334024156
AK187113
AKOS015918266
AKOS024284363
AKOS025296077
AN-19905
Auryxia
C6H5FeO7
C6H5O7.Fe
CCRIS 6843
Citric Acid Iron
Citric acid iron(III) salt
Citric acid, iron salt
Citric acid, iron(3+) salt
Citric acid, iron(3+) salt (1:1)
CTK1C2869
CTK4D4143
D04CJL
D10705
DB09162
DTXSID0037657
DTXSID50165350
EINECS 219-045-4
EINECS 222-536-6
EINECS 249-117-0
Eisencitrat
eUeUEaIu
Fe(III)-citrate complex (1:1)
Ferric citrate (USAN)
Ferric citrate (VAN)
Ferric citrate [USAN]
ferric citrate hydrate
Ferric citrate monohydrate
Ferric citrate tetrahydrate
Ferric citrate, BioReagent, suitable for cell culture
Ferric citrate, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
FERRICCITRATE
Ferrous citrate dibasic
ferrum citricum
FT-0626407
FT-0627304
FT-0652224
FT-0696578
H260
HUTBITLDXCEAPZ-UHFFFAOYSA-N
Hyperphosphatemia therapy, Panion/Keryx
I14-60931
I14-8077
Iron (III) citrate
Iron 2-hydroxy-1,2,3-propanetricarboxylate
Iron citrate
Iron citrate tetrahydrate
Iron citrate, FeC6H5O7
Iron III citrate
Iron, (hydrogen citrato(3-))-
Iron, [hydrogen citrato(3-)]-
Iron( cento) citrate hydrate
iron(3+) 2-hydroxypropane-1,2,3-tricarboxylate tetrahydrate
iron(3+) citrate
iron(3+) ion 2-hydroxypropane-1,2,3-tricarboxylate
iron(3+); 2-oxidanylpropane-1,2,3-tricarboxylate
Iron(III) citrate
Iron(III) citrate hydrate
IRON(III) CITRATE HYDRATE, 98
Iron(III) citrate tetrahydrate
Iron(III) citrate tribasic
Iron(III) citrate tribasic hydrate
Iron(III) citrate tribasic monohydrate
Iron(III) citrate tribasic monohydrate, 18-20% Fe basis (T)
Iron(III) citrate tribasic monohydrate, puriss., 18-20%
Iron(III) citrate, technical grade
Iron(III)-citrate
Iron[III]citrate
JTT 751
JTT-751
KRX-0502
KS-0000108D
KSC534C4H
LS-7395
MCULE-2140052675
MFCD00013098
Nephoxil
NPFOYSMITVOQOS-UHFFFAOYSA-K
NSC 112227
NSC-112227
NSC112227
OR020149
OR059024
OR16950
OR177435
OR253005
OR259086
PBF-1681
SBB017245
SC-65203
SCHEMBL317585
SCHEMBL42945
SCHEMBL66314
ST075192
TR-037246
TRA0022730
UNII-334S8T6LKE
UNII-63G354M39Z
Zerenex
ZX-AT022088

US Patents and Regulatory Information for ferric citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for ferric citrate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,750,715 Method of reversing, preventing, delaying or stabilizing soft tissue calcification ➤ Try a Free Trial
9,889,113 Method for reversing, preventing, delaying or stabilizing soft tissue calcification ➤ Try a Free Trial
9,913,821 Ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Chinese Patent Office
Fuji
Citi
Cerilliant
Chubb
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.